Dr. Soares is a Professor and former Chair of the Department of Psychiatry at Queen’s University School of Medicine in Kingston, Ontario – Canada. He currently serves as Director for the Centre for Psychedelic Heath and Research at Providence Care Hospital & Queen’s University, Executive Lead for the Canadian Biomarker Integration Network in Depression (CAN-BIND) and Regional Lead for Mental Health and Addictions, Ontario Health East.

Dr. Soares trained as a psychiatrist, completed his Ph.D. on estrogen effects for the management of depression in midlife women and pursued a postdoctoral fellowship in Perinatal and Reproductive Psychiatry at the Massachusetts General Hospital, Harvard Medical School.

His research has focused on the design and implementation of clinical trials in depression, with a primary focus on novel hormonal and non-hormonal options for midlife women experiencing mood and anxiety disorders, vasomotor symptoms, and sleep problems.  He is currently the president of the  Menopause Society.

His work has also explored  digital health technologies for treatment monitoring and relapse prevention in depression and sleep disturbances, and the role of psychedelics for the management of psychiatric disorders and existential distress in late-stage cancer.

He is a sought-after educator with more than 240 presentations at national and international meetings and more than 200 peer-reviewed publications in the areas of mood disorders and women’s mental health, including JAMA, Nature, American Journal of Psychiatry, among others. His body of work has more than 13,000 citations to date.